BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27405596)

  • 1. Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians.
    Arabi YM; Al-Enezi F; Longuere KS; Balkhy HH; Al-Sultan M; Al-Omari A; Al-Hameed FM; Carson G; Shindo N; Fowler R
    BMC Anesthesiol; 2016 Jul; 16(1):36. PubMed ID: 27405596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
    Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
    Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Middle East Respiratory Syndrome Coronavirus epidemic impact on healthcare workers' risk perceptions, work and personal lives.
    Alsubaie S; Hani Temsah M; Al-Eyadhy AA; Gossady I; Hasan GM; Al-Rabiaah A; Jamal AA; Alhaboob AA; Alsohime F; Somily AM
    J Infect Dev Ctries; 2019 Oct; 13(10):920-926. PubMed ID: 32084023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, Attitudes and Behaviours of Healthcare Workers in the Kingdom of Saudi Arabia to MERS Coronavirus and Other Emerging Infectious Diseases.
    Alsahafi AJ; Cheng AC
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27929452
    [No Abstract]   [Full Text] [Related]  

  • 5. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol.
    Arabi Y; Balkhy H; Hajeer AH; Bouchama A; Hayden FG; Al-Omari A; Al-Hameed FM; Taha Y; Shindo N; Whitehead J; Merson L; AlJohani S; Al-Khairy K; Carson G; Luke TC; Hensley L; Al-Dawood A; Al-Qahtani S; Modjarrad K; Sadat M; Rohde G; Leport C; Fowler R
    Springerplus; 2015; 4():709. PubMed ID: 26618098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the level of concern among hospital-based health-care workers regarding MERS outbreaks in Saudi Arabia.
    Abolfotouh MA; AlQarni AA; Al-Ghamdi SM; Salam M; Al-Assiri MH; Balkhy HH
    BMC Infect Dis; 2017 Jan; 17(1):4. PubMed ID: 28049440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia.
    Al Ghamdi M; Alghamdi KM; Ghandoora Y; Alzahrani A; Salah F; Alsulami A; Bawayan MF; Vaidya D; Perl TM; Sood G
    BMC Infect Dis; 2016 Apr; 16():174. PubMed ID: 27097824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
    Arabi YM; Alothman A; Balkhy HH; Al-Dawood A; AlJohani S; Al Harbi S; Kojan S; Al Jeraisy M; Deeb AM; Assiri AM; Al-Hameed F; AlSaedi A; Mandourah Y; Almekhlafi GA; Sherbeeni NM; Elzein FE; Memon J; Taha Y; Almotairi A; Maghrabi KA; Qushmaq I; Al Bshabshe A; Kharaba A; Shalhoub S; Jose J; Fowler RA; Hayden FG; Hussein MA;
    Trials; 2018 Jan; 19(1):81. PubMed ID: 29382391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic, clinical, and outcomes of confirmed cases of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in Najran, Kingdom of Saudi Arabia (KSA); A retrospective record based study.
    Al Sulayyim HJ; Khorshid SM; Al Moummar SH
    J Infect Public Health; 2020 Sep; 13(9):1342-1346. PubMed ID: 32354534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and attitudes towards Middle East respiratory sydrome-coronavirus (MERS-CoV) among health care workers in south-western Saudi Arabia.
    Asaad A; El-Sokkary R; Alzamanan M; El-Shafei M
    East Mediterr Health J; 2020 Apr; 26(4):435-442. PubMed ID: 32338362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study.
    Aleanizy FS; Mohmed N; Alqahtani FY; El Hadi Mohamed RA
    BMC Infect Dis; 2017 Jan; 17(1):23. PubMed ID: 28056850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.
    Arabi YM; Arifi AA; Balkhy HH; Najm H; Aldawood AS; Ghabashi A; Hawa H; Alothman A; Khaldi A; Al Raiy B
    Ann Intern Med; 2014 Mar; 160(6):389-97. PubMed ID: 24474051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016.
    Bleibtreu A; Jaureguiberry S; Houhou N; Boutolleau D; Guillot H; Vallois D; Lucet JC; Robert J; Mourvillier B; Delemazure J; Jaspard M; Lescure FX; Rioux C; Caumes E; Yazdanapanah Y
    BMC Infect Dis; 2018 Jul; 18(1):331. PubMed ID: 30012113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia.
    Briese T; Mishra N; Jain K; Zalmout IS; Jabado OJ; Karesh WB; Daszak P; Mohammed OB; Alagaili AN; Lipkin WI
    mBio; 2014 Apr; 5(3):e01146-14. PubMed ID: 24781747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections.
    Zumla A; Azhar EI; Arabi Y; Alotaibi B; Rao M; McCloskey B; Petersen E; Maeurer M
    Int J Infect Dis; 2015 Nov; 40():71-4. PubMed ID: 26365771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.
    Müller MA; Meyer B; Corman VM; Al-Masri M; Turkestani A; Ritz D; Sieberg A; Aldabbagh S; Bosch BJ; Lattwein E; Alhakeem RF; Assiri AM; Albarrak AM; Al-Shangiti AM; Al-Tawfiq JA; Wikramaratna P; Alrabeeah AA; Drosten C; Memish ZA
    Lancet Infect Dis; 2015 May; 15(5):559-64. PubMed ID: 25863564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.